Position in RPRX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$27,586
+$10,739 QoQ
Shares Held
492
+12.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#549
of 641 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Kingdom Financial Group LLC. holds $98,119 across 10 Biotechnology names. RPRX ranks #2 (28.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
392 | $44,437 | |
| 2 | RPRX |
Royalty Pharma plc
This page
|
492 | $27,586 | |
| 3 | EXEL |
Exelixis, Inc.
|
460 | $25,028 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3 | $903 | |
| 5 | ALEC |
Alector, Inc.
|
48 | $96 | |
| 6 | BEAM |
Beam Therapeutics Inc.
|
1 | $34 | |
| 7 | BNTX |
BioNTech SE
|
0 | $30 | |
| 8 | NTLA |
Intellia Therapeutics, Inc.
|
0 | $3 |
All Filings in RPRX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,586 | 492 | Shares | Sole | 2026-08-07 | |
| 2025-12-31 | $16,847 | 436 | Shares | Sole | 2026-02-06 | |
| No filing history on record for this holder in this stock. | ||||||